Aldose reductase: A novel therapeutic target for inflammatory pathologies

Keyphrases

• Novel Therapeutic Targets 100%
• Aldose Reductase 100%
• Inflammatory Pathologies 100%
• Diabetes Complications 66%
• Aldose Reductase Inhibitor 66%
• Cardiovascular Disease 33%
• Liver 33%
• Clinical Trials 33%
• Colon Cancer 33%
• Human Cancer 33%
• Sepsis 33%
• Colon 33%
• Asthma 33%
• Lipid Peroxidation 33%
• Inflammatory Diseases 33%
• Breast 33%
• Glucose Metabolism 33%
• Health Anxiety 33%
• Sorbitol 33%
• Aldehydes 33%
• Anti-inflammatory Drugs 33%
• Glutathione Conjugates 33%
• Uveitis 33%
• Polyol Pathway 33%
• Catalytic Activity 33%
• Cancer Disease 33%
• Rate-limiting Step 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Aldehyde Reductase 100%
• Diabetic Complication 66%
• Aldose Reductase Inhibitor 66%
• Glucose 66%
• Clinical Trial 33%
• Malignant Neoplasm 33%
• Glutathione 33%
• Atherosclerosis 33%
• Sepsis 33%
• Inflammatory Disease 33%
• Asthma 33%
• Uveitis 33%
• Antiinflammatory Agent 33%
• Sorbitol 33%
• Colon Carcinoma 33%
• Lipid 33%
• Cardiovascular Disease 33%
• Aldehyde 33%
• Polyol 33%